Ceritinib/crizotinibDevelopment of resistance in EML4-ALK-positive non-small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1635卷 / 1期
关键词：
D O I：
10.1007/s40278-017-25324-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 75
相关论文
共 50 条
  • [31] Efficacy of Ceritinib After Alectinib for ALK-positive Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Tsuji, Takahiro
    Nomizo, Takashi
    Yasuda, Yuto
    Yamamoto, Tomoko
    Ajimizu, Hitomi
    Hirai, Toyohiro
    IN VIVO, 2018, 32 (06): : 1587 - 1590
  • [32] Analysis of a Mouse Model for EML4-ALK-Positive Lung Cancer.
    Soda, M.
    Takada, S.
    Takeuchi, K.
    Ishikawa, Y.
    Sugiyama, Y.
    Mano, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [33] Cytological Feature of EML4-ALK-Positive Lung Adenocarcinoma
    Nakamura, Harumi
    Tsuta, Koji
    Yoshida, Akihiko
    Shibuki, Yasuo
    Tsuda, Hitoshi
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S406 - S407
  • [34] The biology and treatment of EML4-ALK non-small cell lung cancer
    Sasaki, Takaaki
    Rodig, Scott J.
    Chirieac, Lucian R.
    Janne, Pasi A.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (10) : 1773 - 1780
  • [35] EML4-ALK fusion gene in non-small cell lung cancer
    Lei, Yu
    Lei, Yan
    Shi, Xiang
    Wang, Jingjing
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [36] Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With EML4-ALK-Positive Non-Small-Cell Lung Cancer
    Tamiya, Akihiro
    Okamoto, Isamu
    Miyazaki, Masaki
    Shimizu, Shigeki
    Kitaichi, Masanori
    Nakagawa, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : E15 - E17
  • [37] Ceritinib: an orphan drug for ALK positive non-small cell lung cancer with robust clinical evidence
    Rolfo, Christian
    Arias, David
    Gandia, Jose Ferri
    Manca, Paolo
    Santos, Edgardo
    Raez, Luis E.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (12): : 991 - 997
  • [38] Clinical Outcomes and ALK Resistance Mutations in ALK plus Non-Small Cell Lung Cancer According to EML4-ALK Variant
    Lin, J.
    Zhu, V.
    Yoda, S.
    Yeap, B.
    Jessop, N.
    Schrock, A.
    Dagogo-Jack, I.
    Gowen, K.
    Stephens, P. J.
    Ross, J.
    Ali, S.
    Miller, V.
    Gainor, J.
    Hata, A.
    Iafrate, A.
    Ou, S.
    Shaw, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1828 - S1828
  • [39] EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer
    Jin, Guang
    Jeon, Hyo-Sung
    Lee, Eung Bae
    Kang, Hyo-Gyoung
    Yoo, Seung Soo
    Lee, Shin Yup
    Lee, Jae Hee
    Cha, Sung Ick
    Park, Tae In
    Kim, Chang Ho
    Jheon, Sang Hoon
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (02) : 228 - 230
  • [40] Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
    Verzura, Maria
    Batagelj, Emilio
    Bagnes, Claudia
    Martin, Claudio
    Enrico, Diego
    Richardet, Eduardo
    De la Iglesia, Paola
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 77 - 81
12345